References
- Adeagbo, O. A., Mthiyane, N., Herbst, C., Mee, P., Neuman, M., Dreyer, J., Chimbindi, N., Smit, T., Okesola, N., Johnson, C., Hatzold, K., Seeley, J., Cowan, F., Corbett, L., & Shahmanesh, M. (2019). Cluster randomised controlled trial to determine the effect of peer delivery HIV self-testing to support linkage to HIV prevention among young women in rural KwaZulu-Natal, South Africa: A study protocol. BMJ Open, 9(12), e033435. https://doi.org/https://doi.org/10.1136/bmjopen-2019-033435
- Attride-Sterling, J. (2001). Thematic networks: An analystic tool for qualitative research. Qualitative Research, 1(3), 385–405. https://doi.org/https://doi.org/10.1177/146879410100100307
- AVAC. (2019). Global PrEP Tracker. Retrieved December 28 from, https://www.prepwatch.org/resource/global-prep-tracker/
- Baeten, J. M., Hendrix, C. W., & Hillier, S. L. (2020). Topical microbicides in HIV prevention: State of the promise. Annual Review of Medicine, 71(1), 361–377. https://doi.org/https://doi.org/10.1146/annurev-med-090518-093731
- Baron, D., Scorgie, F., Ramskin, L., Khoza, N., Schutzman, J., Stangl, A., Harvey, S., Delany-Moretlwe, S. & Team, E. S (2020). You talk about problems until you feel free: South African adolescent girls’ and young women's narratives on the value of HIV prevention peer support clubs. BMC Public Health, 20(1), 1016. https://doi.org/https://doi.org/10.1186/s12889-020-09115-4
- Celum, C. L., Delany-Moretlwe, S., Baeten, J. M., van der Straten, A., Hosek, S., Bukusi, E. A., McConnell, M., Barnabas, R. V., & Bekker, L. G. (2019). HIV pre-exposure prophylaxis for adolescent girls and young women in Africa: From efficacy trials to delivery. Journal of the International AIDS Society, 22(Suppl 4), e25298. https://doi.org/https://doi.org/10.1002/jia2.25298
- Dunbar, M., Kripke, K., Haberer, J., Castor, D., Dalal, S., Mukoma, W. M., Saiqa, P., Reed, P., Subedar, J., Were, H., & Warren, D., & Kristine, M. T. (2019). Understanding and measuring uptake and coverage of oral pre-exposure prophylaxis delivery among adolescent girls and young women in sub-saharan Africa. Sexual Health, 15(6), 513–521. https://doi.org/https://doi.org/10.1071/SH18061
- Hsieh, H. F., & Shannon, S. E. (2005). Three approaches to qualitative content analysis. Qualitative Health Research, 15(9), 1277–1288. https://doi.org/10.1177/1049732305276687
- Joseph Davey, D. L., Daniels, J., Beard, C., Mashele, N., Bekker, L. G., Dovel, K., Ncayiyana, J., Coates, T. J., & Myer, L. (2020). Healthcare provider knowledge and attitudes about pre-exposure prophylaxis (PrEP) in pregnancy in Cape Town, South Africa. AIDS Care, 32(10):1290–1294. https://doi.org/https://doi.org/10.1080/09540121.2020.1782328
- Kinuthia, J., Pintye, J., Abuna, F., Mugwanya, K. K., Lagat, H., Onyango, D., Begnel, E., Dettinger, J., Baeten, J. M., & John-Stewart, G. (2020). Pre-exposure prophylaxis uptake and early continuation among pregnant and post-partum women within maternal and child health clinics in Kenya: Results from an implementation programme. The Lancet HIV, 7(1), e38–e48. https://doi.org/https://doi.org/10.1016/S2352-3018(19)30335-2
- Krogstad, E. A., Atujuna, M., Montgomery, E. T., Minnis, A., Ndwayana, S., Malapane, T., Shapley-Quinn, M. K., Manenzhe, K., Bekker, L. G., & van der Straten, A. (2018). Perspectives of South African youth in the development of an implant for HIV prevention. Journal of the International AIDS Society, 21(8), e25170. https://doi.org/https://doi.org/10.1002/jia2.25170
- Luecke, E. H., Cheng, H., Woeber, K., Nakyanzi, T., Mudekunye-Mahaka, I. C., van der Straten, A., & Team, M.-D. S. (2016). Stated product formulation preferences for HIV pre-exposure prophylaxis among women in the VOICE-D (MTN-003D) study. Journal of the International AIDS Society, 19(1), 20875. https://doi.org/https://doi.org/10.7448/IAS.19.1.20875
- Ministry of Health, National AIDS & STI Control Programme. (July 2016). Guidelines on use of antiretroviral drugs for treating and preventing HIV infection in Kenya 2016. http://emtct-iatt.org/wp-content/uploads/2016/09/Guidelines-on-Use-of-Antiretroviral-Drugs-for-Treating-and-Preventing-HI … .pdf
- Minnis, A. M., Atujuna, M., Browne, E. N., Ndwayana, S., Hartmann, M., Sindelo, S., Ngcwayi, N., Boeri, M., Mansfield, C., Bekker, L. G., & Montgomery, E. T. (2020). Preferences for long-acting pre-exposure prophylaxis (PrEP) for HIV prevention among South African youth: Results of a discrete choice experiment. Journal of the International AIDS Society, 23(6), e25528. https://doi.org/https://doi.org/10.1002/jia2.25528
- Minnis, A. M., Roberts, S. T., Agot, K., Weinrib, R., Ahmed, K., Manenzhe, K., Owino, F., van der Straten, A., & Team, T. S. (2018). Young women's ratings of three placebo multipurpose prevention technologies for HIV and pregnancy prevention in a randomized, cross-over study in Kenya and South Africa. AIDS and Behavior, 22(8), 2662–2673. https://doi.org/https://doi.org/10.1007/s10461-018-2078-5
- Montgomery, E. T., Mensch, B., Musara, P., Hartmann, M., Woeber, K., Etima, J., & van der Straten, A. (2017). Misreporting of product adherence in the MTN-003/VOICE trial for HIV prevention in Africa: Participants’ explanations for dishonesty. AIDS and Behavior, 21(2), 481–491. https://doi.org/https://doi.org/10.1007/s10461-016-1609-1
- Montgomery, E. T., van der Straten, A., Stadler, J., Hartmann, M., Magazi, B., Mathebula, F., Laborde, N., & Soto-Torres, L. (2015). Male partner influence on women's HIV prevention trial participation and use of pre-exposure prophylaxis: The importance of “understanding”. AIDS and Behavior, 19(5), 784–793. https://doi.org/https://doi.org/10.1007/s10461-014-0950-5
- Mugo, N. R., Hong, T., Celum, C., Donnell, D., Bukusi, E. A., John-Stewart, G., Wangisi, J., Were, E., Heffron, R., Matthews, L. T., Morrison, S., Ngure, K., & Baeten, J. M. (2014). Pregnancy incidence and outcomes among women receiving preexposure prophylaxis for HIV prevention: A randomized clinical trial. JAMA, 312(4), 362–371. https://doi.org/https://doi.org/10.1001/jama.2014.8735
- Mugwanya, K. K., Pintye, J., Kinuthia, J., Abuna, F., Lagat, H., Begnel, E. R., Dettinger, J. C., John-Stewart, G., & Baeten, J. M. (2019). Integrating preexposure prophylaxis delivery in routine family planning clinics: A feasibility programmatic evaluation in Kenya. PLOS Medicine, 16(9), e1002885. https://doi.org/https://doi.org/10.1371/journal.pmed.1002885
- Murnane, P. M., Heffron, R., Ronald, A., Bukusi, E. A., Donnell, D., Mugo, N. R., Were, E., Mujugira, A., Kiarie, J., Celum, C., Baeten, J. M., & Team, P. P. S. (2014). Pre-exposure prophylaxis for HIV-1 prevention does not diminish the pregnancy prevention effectiveness of hormonal contraception. Aids (London, England), 28(12), 1825–1830. https://doi.org/https://doi.org/10.1097/QAD.0000000000000290
- National AIDS Control Council. (2017). Kisumu county HIV & AIDS strategic plan. https://nacc.or.ke/mdocs-posts/kisumu-county-hiv-aids-strategic-plan/
- Oluoch, L., Mugo, N., Roxby, A., Wald, A., Selke, S., Magaret, A., Ngure, K., Micheni, M., Gakuo, S., Choban, B., & Kiptinness, C. (2019). Low uptake of preexposure prophylaxis among Kenyan adolescent girls at risk of HIV CROI Conference. CROI. https://www.croiconference.org/sessions/low-uptake-preexposure-prophylaxis-among-kenyan-adolescent-girls-risk-hiv
- Patel, R. C., Baeten, J. M., Heffron, R., Hong, T., Davis, N. L., Nanda, K., Coombs, R. W., Lingappa, J. R., Bukusi, E. A., Hurst, S., Thomas, K. K., Kourtis, A. P., Mugo, N., & Partners in Prevention HSVHIV Transmission Study and Partners PrEP Study Teams (2017). Brief report: Hormonal contraception is not associated with reduced ART effectiveness Among women initiating ART: Evidence from longitudinal data. JAIDS Journal of Acquired Immune Deficiency Syndromes, 75(1), 91–96. https://doi.org/https://doi.org/10.1097/QAI.0000000000001339
- Pintye, J., Beima-Sofie, K. M., Kimemia, G., Ngure, K., Trinidad, S. B., Heffron, R. A., Baeten, J. M., Odoyo, J., Mugo, N., Bukusi, E. A., Kelley, M. C., & John-Stewart, G. C. (2017). I Did Not want to give birth to a child who has HIV: Experiences using PrEP during pregnancy among HIV-Uninfected Kenyan women in HIV-serodiscordant couples. JAIDS Journal of Acquired Immune Deficiency Syndromes, 76(3), 259–265. https://doi.org/https://doi.org/10.1097/QAI.0000000000001516
- Pintye, J., Beima-Sofie, K. M., Makabong, O. P., Njoroge, A., Trinidad, S. B., Heffron, R. A., Baeten, J. M., Celum, C., Matemo, D., Kinuthia, J., Kelley, M. C., & John-Stewart, G. C. (2018a). HIV-Uninfected Kenyan adolescent and young women share perspectives on using pre-exposure prophylaxis during pregnancy. AIDS Patient Care and STDs, 32(12), 538–544. https://doi.org/https://doi.org/10.1089/apc.2018.0058
- Pintye, J., Kinuthia, J., Roberts, D. A., Wagner, A. D., Mugwanya, K., Abuna, F., Lagat, H., Owiti, G., Levin, C. E., Barnabas, R. V., Baeten, J. M., & John-Stewart, G. (2018b). Brief report: Integration of PrEP services into routine antenatal and postnatal care: Experiences from an implementation program in Western Kenya. JAIDS Journal of Acquired Immune Deficiency Syndromes, 79(5), 590–595. https://doi.org/https://doi.org/10.1097/QAI.0000000000001850
- Prochaska, J. O., & Velicer, W. F. (1997). The transtheoretical model of health behavior change. American Journal of Health Promotion, 12(1), 38–48. https://doi.org/https://doi.org/10.4278/0890-1171-12.1.38
- Pyra, M., Heffron, R., Mugo, N. R., Nanda, K., Thomas, K. K., Celum, C., Kourtis, A. P., Were, E., Rees, H., Bukusi, E., Baeten, J. M., & Partners in Prevention HSVHIV Transmission Study and Partners PrEP Study Teams. (2015). Effectiveness of hormonal contraception in HIV-infected women using antiretroviral therapy. Aids (London, England), 29(17), 2353–2359. https://doi.org/https://doi.org/10.1097/QAD.0000000000000827
- Simoni, J. M., Beima-Sofie, K., Amico, K. R., Hosek, S. G., Johnson, M. O., & Mensch, B. S. (2019). Debrief reports to expedite the impact of qualitative research: Do they accurately capture data from In-depth interviews? AIDS and Behavior, 23(8), 2185–2189. https://doi.org/https://doi.org/10.1007/s10461-018-02387-3
- Tarleton, J., Chen, B. A., Meyn, L. A., Hendrix, C. W., Marzinke, M. A., & Achilles, S. L. (2020). Pharmacokinetic and pharmacodynamic impacts of depot medroxyprogesterone acetate use on HIV pre-exposure prophylaxis in women. JAIDS Journal of Acquired Immune Deficiency Syndromes, 85(2):182–188. https://doi.org/https://doi.org/10.1097/QAI.0000000000002421
- UNAIDS. (2014). The Gap Report. J. U. N. P. o. H. A. (UNAIDS). http://www.unaids.org/en/resources/documents/2014/20140716_UNAIDS_gap_report
- UNAIDS. (2017). Ending AIDS: progress towards the 90–90–90 targets. Retrieved November 9 from https://www.unaids.org/en/resources/documents/2017/20170720_Global_AIDS_update_2017
- van der Straten, A., Ryan, J. H., Reddy, K., Etima, J., Taulo, F., Mutero, P., Taylor, J., Piper, J., Musara, P., & Team, M.-M. S. (2020). Influences on willingness to use vaginal or oral HIV PrEP during pregnancy and breastfeeding in Africa: The multisite MAMMA study. Journal of the International AIDS Society, 23(6), e25536. https://doi.org/https://doi.org/10.1002/jia2.25536
- van der Straten, A., Stadler, J., Montgomery, E., Hartmann, M., Magazi, B., Mathebula, F., Schwartz, K., Laborde, N., & Soto-Torres, L. (2014). Women's experiences with oral and vaginal pre-exposure prophylaxis: The VOICE-C qualitative study in johannesburg, South Africa. PLoS One, 9(2), e89118. https://doi.org/https://doi.org/10.1371/journal.pone.0089118
- World Health Organization. (2018). WHO implementation tool for pre-exposure prophylaxis (PrEP) of HIV Infection, Module 12: Adolescents and young adults.